{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:09:58Z","timestamp":1790712598083,"version":"4.1.0"},"reference-count":36,"publisher":"Baishideng Publishing Group Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJP"],"published-print":{"date-parts":[[2022,2,19]]},"DOI":"10.5498\/wjp.v12.i2.298","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T14:03:56Z","timestamp":1644933836000},"page":"298-307","source":"Crossref","is-referenced-by-count":17,"title":["Associated mortality risk of atypical antipsychotic medication in individuals with dementia"],"prefix":"10.5498","volume":"12","author":[{"given":"Peter","family":"Phiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Engelthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Delanerolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanaya","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/60.5.622"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2796"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.6930"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2217\/cer.13.33"},{"key":"B5","unstructured":"Banerjee S.   The use of antipsychotic medication for people with dementia: time for action. A report for the Minister of State for Care Services. [cited 27 May 2021]. Available from: http:\/\/psychrights.org\/Research\/Digest\/NLPs\/BanerjeeReportOnGeriatricNeurolepticUse.pdf"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-016-0060-6"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-11-200706050-00006"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.15.1934"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4101"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2021.102086"},{"key":"B11","unstructured":"Python.   Python 3.8.3. [cited 26 May 2021]. Available from: https:\/\/www.python.org\/downloads\/release\/python-383\/"},{"key":"B12","unstructured":"McKinney W & PyData Development Team.   Pandas: powerful Python data analysis toolkit. [cited 27 May 2021]. Available from: https:\/\/pandas.pydata.org\/pandas-docs\/version\/0.25.3\/pandas.pdf"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2649-2"},{"key":"B14","unstructured":"Testing the proportional hazard assumptions. [cited 27 May 2021]. Available from: https:\/\/lifelines.readthedocs.io\/en\/latest\/jupyter_notebooks\/Proportional%20hazard%20assumption.html"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1109\/MCSE.2007.55"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0302-8"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/69.1.239"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ajps.12176"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.122499"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-012-0013-4"},{"key":"B21","unstructured":"Wooltorton E. Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. CMAJ 2002; 167: 1269-1270"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040539"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0830-z"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105056524"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S180303"},{"key":"B26","unstructured":"Aboraya A, Fullen JE, Ponieman BL, Makela EH, Latocha M. Hyperprolactinemia associated with risperidone: a case report and review of literature. Psychiatry (Edgmont) 2004; 1: 29-31"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4103\/2350-0298.184680"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107078281"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/014107680009300903"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S117321"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.02007.x"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119845715"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70295-3"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.12.007"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.3763"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8"}],"container-title":["World Journal of Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2220-3206\/full\/v12\/i2\/298.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T14:04:50Z","timestamp":1644933890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2220-3206\/full\/v12\/i2\/298.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,19]]},"references-count":36,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5498\/wjp.v12.i2.298","relation":{},"ISSN":["2220-3206"],"issn-type":[{"value":"2220-3206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,19]]}}}